Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-08

Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study of tezepelumab in children with asthma has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2024-01-08